Postmarket surveillance of 3D-printed implants for sacroiliac joint fusion
- PMID: 30319290
- PMCID: PMC6168000
- DOI: 10.2147/MDER.S180958
Postmarket surveillance of 3D-printed implants for sacroiliac joint fusion
Abstract
Background: Government regulations require postmarket surveillance for cleared/approved medical devices. Trend analysis of newly marketed devices may help to confirm device-related safety or uncover other device or procedure-related problems.
Methods: Complaints related to the use of 3D-printed triangular titanium implants for sacroiliac joint (SIJ) fusion were compared with those of the prior machined version of the device manufactured with a titanium plasma spray (TPS) coating. Event rates were calculated either by dividing event counts by numbers of surgeries or, for late events, using Kaplan-Meier survival analysis.
Results: Three types of complaints with nontrial frequencies were identified. Issues in instruments occurred at a low and constant rate (1.3%). Using Kaplan-Meier analysis, pain-related complaints occurred at a low and similar rate in both groups (<0.5%). The 1-year cumulative probability of surgical revision was low in both the 3D and machined versions of the device (1.5% for machined and 1% for 3D printed, P=0.0408 for difference). No implant breakages or migrations were identified in either group, and overall rates were similar to a previously published report.
Conclusion: The 3D-printed version of triangular titanium implant was associated with complaint and adverse event rates similar to those for the prior machined version of the device.
Keywords: adverse events; complaint analysis; permanent implants; postmarket surveillance; quality system; sacroiliac joint fusion.
Conflict of interest statement
Disclosure All authors are employees of SI-BONE, Inc., which manufactures the implants described herein. The authors report no other conflicts of interest in this work.
Figures


References
-
- FDA [webpage on the Internet] Medical Device Reporting. Code of Federal Regulations, Title 21, Part 803. [Accessed August 18, 2018]. Available from: http://www.access-data.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?C....
-
- Guidelines on a medical devices vigilance system MEDDEV 2.12.1 rev 8. 2013. [Accessed September 10, 2018]. Available from: http://ec.europa.eu/DocsRoom/documents/15506.
-
- Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc’h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am. 2000;82(4):457–477. - PubMed
-
- FDA [webpage on the Internet] MAUDE – Manufacturer and User Facility Device Experience. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm. Accessed July 11, 2018.
-
- Bernard TN, Kirkaldy-Willis WH. Recognizing specific characteristics of nonspecific low back pain. Clin Orthop Relat Res. 1987;217:266–280. - PubMed
LinkOut - more resources
Full Text Sources